TY - JOUR
T1 - The Tyr978X BRCA1 mutation
T2 - Occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews
AU - Quintana-Murci, Lluís
AU - Gal, Inbar
AU - Bakhan, Tangiz
AU - Quach, Hélène
AU - Sayar, S. Hamid
AU - Shiri-Sverdlov, Ronit
AU - Baruch, Ruth Gershoni
AU - McElreavey, Ken
AU - Dagan, Efrat
AU - Narod, Steven
AU - Friedman, Eitan
PY - 2005/6
Y1 - 2005/6
N2 - Background: The Tyr978X BRCA1 mutation is a founder mutation detected in high-risk Iraqi-Iranian Jewish families as well as in the general non-Ashkenazi population. The same mutation was also reported in non-Jewish high-risk women from Canada. Its occurrence in non-Jewish individuals from Iran has never been tested. Objective: Assess the occurrence rate of Tyr978X BRCA1 germline mutation in the general population of Iranian non- Jewish individuals and compare the BRCA1-linked haplotype of Jewish and non-Jewish mutation carriers. Methods: PCR amplification of the relevant fragment of the BRCA1 gene, followed by restriction enzyme digestion that differentiates wild type from mutant allele. For haplotyping, 7 BRCA1-linked markers were used. The tested population included 442 apparently healthy Iranian non-Jewish individuals, and 17 mutation carriers from Israel and Canada. Results: The Tyr978X BRCA1 mutation was not detected in any Iranian non-Jewish individual. The intragenic haplotype of all Jewish Israeli mutation carriers was identical, but differed from that of Canadian non-Jews in two intragenic markers. Conclusions: The Tyr978X BRCA1 mutation which is a founder mutation in Jews, may be a hot spot in non-Jewish high risk women, and probably does not represent a rare sequence variant in Iranian non-Jews.
AB - Background: The Tyr978X BRCA1 mutation is a founder mutation detected in high-risk Iraqi-Iranian Jewish families as well as in the general non-Ashkenazi population. The same mutation was also reported in non-Jewish high-risk women from Canada. Its occurrence in non-Jewish individuals from Iran has never been tested. Objective: Assess the occurrence rate of Tyr978X BRCA1 germline mutation in the general population of Iranian non- Jewish individuals and compare the BRCA1-linked haplotype of Jewish and non-Jewish mutation carriers. Methods: PCR amplification of the relevant fragment of the BRCA1 gene, followed by restriction enzyme digestion that differentiates wild type from mutant allele. For haplotyping, 7 BRCA1-linked markers were used. The tested population included 442 apparently healthy Iranian non-Jewish individuals, and 17 mutation carriers from Israel and Canada. Results: The Tyr978X BRCA1 mutation was not detected in any Iranian non-Jewish individual. The intragenic haplotype of all Jewish Israeli mutation carriers was identical, but differed from that of Canadian non-Jews in two intragenic markers. Conclusions: The Tyr978X BRCA1 mutation which is a founder mutation in Jews, may be a hot spot in non-Jewish high risk women, and probably does not represent a rare sequence variant in Iranian non-Jews.
KW - BRCA1
KW - Founder mutation
KW - Population screen
KW - Shared haplotype
UR - http://www.scopus.com/inward/record.url?scp=21244457304&partnerID=8YFLogxK
U2 - 10.1007/s10689-004-2101-z
DO - 10.1007/s10689-004-2101-z
M3 - Article
C2 - 15951957
AN - SCOPUS:21244457304
SN - 1389-9600
VL - 4
SP - 85
EP - 88
JO - Familial Cancer
JF - Familial Cancer
IS - 2
ER -